Differences in distribution of polymorphisms in genes regulating androgen activity between prostate cancer low-risk Inuit men and high-risk Scandinavians

被引：0
|
作者：
不详
机构：
来源：
EUROPEAN UROLOGY SUPPLEMENTS | 2006年 / 5卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：166 / 166
页数：1
相关论文
共 50 条
  • [41] Prostate Cancer Mortality Associated with Aggregate Polymorphisms in Androgen-Regulating Genes: The Atherosclerosis Risk in the Communities (ARIC) Study
    Prizment, Anna E.
    McSweeney, Sean
    Pankratz, Nathan
    Joshu, Corinne E.
    Hwang, Justin H.
    Platz, Elizabeth A.
    Ryan, Charles J.
    CANCERS, 2021, 13 (08)
  • [42] ASSOCIATION BETWEEN UTILITY LEVELS AND ACTIVE SURVEILLANCE AMONG MEN WITH LOW-RISK PROSTATE CANCER
    Jayadevappa, Ravishankar
    Chhatre, Sumedha
    Malkowicz, S. Bruce
    Talwar, Ruchika
    Guzzo, Thomas
    Wein, Alan
    JOURNAL OF UROLOGY, 2019, 201 (04): : E696 - E696
  • [43] Competing Risk Analysis for Causes of Death in Men With High-Risk Prostate Cancer
    Hunter, G. K.
    Reddy, C. A.
    Stephans, K. L.
    Ciezki, J. P.
    Stephenson, A. J.
    Klein, E. A.
    Mahadevan, A.
    Kupelian, P. A.
    Tendulkar, R. D.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 84 (03): : S414 - S414
  • [44] Identifying high-risk disease masquerading as histomorphologic low-risk endometrial cancer
    Yadav, Siddhartha
    Shahi, Maryam
    McGree, Michaela
    Weaver, Amy
    Bakkum-Gamez, Jamie
    Bosquet, Jesus Gonzalez
    Podratz, Karl
    GYNECOLOGIC ONCOLOGY, 2023, 176 : S158 - S159
  • [45] Autoantibodies and scleroderma phenotype define subgroups at high-risk and low-risk for cancer
    Igusa, Takeru
    Hummers, Laura K.
    Visvanathan, Kala
    Richardson, Carrie
    Wigley, Fredrick M.
    Casciola-Rosen, Livia
    Rosen, Antony
    Shah, Ami A.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 (08) : 1180 - 1187
  • [46] Parallels Between Low-Risk Prostate Cancer and Thyroid Cancer A Review
    Ho, Allen S.
    Daskivich, Timothy J.
    Sacks, Wendy L.
    Zumsteg, Zachary S.
    JAMA ONCOLOGY, 2019, 5 (04) : 556 - 564
  • [47] Effects of androgen deprivation therapy on elderly men with high-risk prostate cancer: PROSARC observational study
    Legido-Gomez, O.
    Rico-Marco, S.
    Lorenzo-Sanchez, M. V.
    Navarro-Jimenez, S.
    Tarraga-Honrubia, M. A.
    Martinez-Ruiz, J.
    Gimenez-Bachs, J. M.
    Donate-Moreno, M. J.
    Mera-Sanchez-Migallon, I. Diaz de
    Segura-Martin, M.
    Alcantud-Corcoles, R.
    Abizanda-Soler, P.
    Salinas-Sanchez, A. S.
    ACTAS UROLOGICAS ESPANOLAS, 2024, 48 (04): : 304 - 310
  • [48] Optimal Duration of Androgen Deprivation in Combination with Radiation Therapy for Japanese Men with High-Risk Prostate Cancer
    Takaha, Natsuki
    Okihara, Koji
    Kamoi, Kazumi
    Kimura, Yasunori
    Yamada, Takeshi
    Kawauchi, Akihiro
    Kobayashi, Kana
    Yamazaki, Hideya
    Nishimura, Tsunehiko
    Miki, Tsuneharu
    UROLOGIA INTERNATIONALIS, 2011, 87 (01) : 28 - 34
  • [49] Association between estrogen and androgen receptor genes and prostate cancer risk
    Nicolaiew, Nathalie
    Cancel-Tassin, Geraldine
    Azzouzi, Abdel Rahmene
    Le Grand, Beatrice
    Mangin, Philippe
    Cormier, Luc
    Fournier, Georges
    Giordanella, Jean-Pierre
    Pouchard, Michel
    Escary, Jean-Louis
    Valeri, Antoine
    Cussenot, Olivier
    EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2009, 160 (01) : 101 - 106
  • [50] Do patients with low-risk and intermediate-risk prostate cancer benefit from androgen deprivation?
    Zietman, AL
    NATURE CLINICAL PRACTICE UROLOGY, 2005, 2 (04): : 160 - 161
12345